Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-20 7:55 pm Unchanged |
2025-03-18 | 13D | Trevi Therapeutics, Inc. TRVI |
New Enterprise Associates 16, L.P. | 15,074,080 15.000% |
0 (Unchanged) |
Filing History |
| 2024-12-23 4:30 pm Purchase |
2024-12-19 | 13D | Marker Therapeutics, Inc. MRKR |
New Enterprise Associates 16, L.P. | 1,625,678 15.200% |
554,250 (+51.73%) |
Filing History |
| 2024-11-08 6:57 pm Unchanged |
2024-11-06 | 13D | Trevi Therapeutics, Inc. TRVI |
New Enterprise Associates 16, L.P. | 15,074,080 18.700% |
0 (Unchanged) |
Filing History |
| 2024-05-21 6:34 pm Purchase |
2024-05-07 | 13D | Trevi Therapeutics, Inc. TRVI |
New Enterprise Associates 16, L.P. | 15,074,080 20.300% |
703,704 (+4.90%) |
Filing History |
| 2024-05-17 6:25 pm Purchase |
2024-05-15 | 13D | Marker Therapeutics, Inc. MRKR |
New Enterprise Associates 16, L.P. | 1,071,428 12.000% |
1,071,428 (New Position) |
Filing History |
| 2024-05-13 7:09 pm Purchase |
2024-05-09 | 13D | Black Diamond Therapeutics, Inc. BDTX |
New Enterprise Associates 16, L.P. | 4,546,947 8.100% |
1,098,190 (+31.84%) |
Filing History |
| 2023-12-29 4:01 pm Sale |
2023-12-21 | 13D | Mirum Pharmaceuticals, Inc. MIRM |
New Enterprise Associates 16, L.P. | 0 0.000% |
-2,186,243 (Position Closed) |
Filing History |
| 2023-06-23 2:32 pm Sale |
2023-06-13 | 13D | Mirum Pharmaceuticals, Inc. MIRM |
New Enterprise Associates 16, L.P. | 2,186,243 5.800% |
-2,000,000 (-47.78%) |
Filing History |
| 2022-10-28 4:48 pm Unchanged |
2022-10-17 | 13D | Akouos, Inc. AKUS |
New Enterprise Associates 16, L.P. | 4,294,207 11.600% |
0 (Unchanged) |
Filing History |
| 2022-10-11 2:01 pm Purchase |
2022-09-21 | 13D | Allakos Inc. ALLK |
New Enterprise Associates 16, L.P. | 6,147,260 7.300% |
6,147,260 (New Position) |
Filing History |
| 2022-05-27 4:34 pm Sale |
2022-05-25 | 13D | Genocea Biosciences, Inc. GNCA |
New Enterprise Associates 16, L.P. | 0 0.000% |
-15,414,495 (Position Closed) |
Filing History |
| 2022-04-25 5:04 pm Purchase |
2022-04-11 | 13D | Trevi Therapeutics, Inc. TRVI |
New Enterprise Associates 16, L.P. | 14,370,376 42.500% |
6,580,526 (+84.48%) |
Filing History |
| 2022-01-05 2:42 pm Sale |
2021-12-27 | 13D | Metacrine, Inc. MTCR |
New Enterprise Associates 16, L.P. | 0 0.000% |
-3,060,527 (Position Closed) |
Filing History |
| 2021-11-02 09:09 am Purchase |
2021-10-18 | 13D | Trevi Therapeutics, Inc. TRVI |
New Enterprise Associates 16, L.P. | 7,789,850 36.100% |
1,851,852 (+31.19%) |
Filing History |
| 2021-04-13 7:08 pm Sale |
2020-07-24 | 13D | Genocea Biosciences, Inc. GNCA |
New Enterprise Associates 16, L.P. | 15,414,495 26.300% |
-1,558,333 (-9.18%) |
Filing History |
| 2021-03-26 10:38 am Purchase |
2021-03-16 | 13D | Marker Therapeutics, Inc. MRKR |
New Enterprise Associates 16, L.P. | 1,446,429 17.400% |
1,446,429 (New Position) |
Filing History |
| 2021-03-10 8:35 pm Sale |
2019-11-29 | 13D | Allakos Inc. ALLK |
New Enterprise Associates 16, L.P. | 0 0.000% |
-2,266,675 (Position Closed) |
Filing History |
| 2020-09-28 2:18 pm Purchase |
2020-09-22 | 13D | Metacrine, Inc. MTCR |
New Enterprise Associates 16, L.P. | 3,060,527 11.800% |
3,060,527 (New Position) |
Filing History |
| 2020-08-03 2:22 pm Purchase |
2020-07-24 | 13D | Genocea Biosciences, Inc. GNCA |
New Enterprise Associates 16, L.P. | 16,972,828 48.700% |
8,004,211 (+89.25%) |
Filing History |
| 2020-07-07 2:00 pm Purchase |
2020-06-30 | 13D | Akouos, Inc. AKUS |
New Enterprise Associates 16, L.P. | 4,294,207 13.200% |
4,294,207 (New Position) |
Filing History |